Related Experiment Video
Updated: May 23, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
[Genomics and clinical research for breast cancer]
François Bertucci1, Daniel Birnbaum
1Département d'oncologie médicale, Institut Paoli-Calmettes, centre de recherche en cancérologie de Marseille, France. bertuccif@marseille.fnclcc.fr
Abstract:
Genomics of breast cancer is paving the way towards more and more tailored treatments. The number of molecularly targeted therapies under development is increasing. In parallel, the high-throughput analyses revealed the molecular heterogeneity of disease, and identified several very different molecular subtypes, numerous and sometimes very scarce molecular alterations, and multigenic signatures predictive for clinical outcome, some of which are being tested in prospective clinical trials. This molecular segmentation of breast cancer and the multitude of new drugs to be tested (alone and in combination) lead to develop clinical trials based on the molecular profile of tumors to guide the patient towards the most suitable drug.
Insights
Genomic insights in breast cancer are enabling personalized treatments. Clinical trials now use tumor molecular profiles to match patients with targeted therapies, improving treatment selection.
Area of Science:
- Genomics
- Molecular Biology
- Oncology
Context:
- Breast cancer exhibits significant molecular heterogeneity.
- High-throughput analyses reveal diverse molecular subtypes and alterations.
- Predictive multigenic signatures are emerging for clinical outcomes.
Purpose:
- To leverage genomic data for personalized breast cancer treatment.
- To align novel molecularly targeted therapies with specific tumor profiles.
- To guide patient selection for clinical trials based on molecular characteristics.
Summary:
- Genomic research in breast cancer is driving the development of tailored therapies.
- Molecular segmentation of tumors identifies subtypes and alterations.
- Clinical trials are increasingly designed around molecular profiles to optimize drug selection.
Impact:
- Facilitates the development of more effective and personalized breast cancer treatments.
- Enhances the precision of drug targeting by matching therapies to specific molecular alterations.
- Improves clinical trial design and patient stratification for better therapeutic outcomes.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
09:01Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Related Concept Videos
Genomics
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Clinical Trials
There are four phases in a clinical trial. A phase one...